BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 775672)

  • 1. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical research and the Council on Dental Therapeutics.
    Scholle RH
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():38-44. PubMed ID: 775673
    [No Abstract]   [Full Text] [Related]  

  • 3. [The concern over better drugs].
    Janssen PA
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):367-90. PubMed ID: 7184277
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing of intraocular drugs for clinical use.
    Kozak I; Cheng L; Silva GA; Freeman WR
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4861-3. PubMed ID: 17962431
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical research in dentistry and the pharmaceutical industry.
    Economy DG
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():32-7. PubMed ID: 775672
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies for evaluation of chemotherapeutic agents for control of plaque and gingivitis.
    Khocht A
    J N J Dent Assoc; 1994; 65(2):15-8, 20-1. PubMed ID: 9520711
    [No Abstract]   [Full Text] [Related]  

  • 7. Current regulatory and scientific considerations for approving biosimilars in Iran.
    Hadavand N; Valadkhani M; Zarbakhsh A
    Biologicals; 2011 Sep; 39(5):325-7. PubMed ID: 21873077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety in clinical trials.
    Wallander MA
    Scand J Prim Health Care Suppl; 1990; 1():89-91. PubMed ID: 2100372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 10. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.